BioAssay Works (BAW) adds 2,000 square feet of additional Manufacturing and Research & Development space, positioning the company to better serve our growing customer base. The COVID-19 pandemic has sharply increased demand for rapid lateral flow tests. BAW is reacting to this increased demand by upgrading our manufacturing facility. BAW remodeled approximately two-thirds of their facility, converting several offices, labs, and storage rooms into an expanded production facility. The facility upgrade includes:

• Improved workflow from raw materials to lateral flow assay components, lateral flow tests, and finished products
• New equipment to improve throughput in our manufacturing processes
• Expanded raw material storage

“It’s exciting to expand our capacity and enhance our capabilities to meet our customer’s needs.”, stated Marc Berman, BAW’s Manufacturing Manager. “The upgrade improves our efficiency through less waste of motion. The improved equipment and remodeled production labs should also improve our throughput.”